School of Medicine


Showing 1-10 of 10 Results

  • Anne Lynn S. Chang, MD

    Anne Lynn S. Chang, MD

    Associate Professor of Dermatology at the Stanford University Medical Center

    Current Research and Scholarly InterestsI have two main research interests:
    1) to better understand and treat patients with aggressive basal cell carcinomas
    2) to better understand the genetic and epigenetic mechanisms of healthy human skin aging and to translate these insights into better care of skin diseases enriched in older patients particularly skin cancer and rosacea

  • Howard Y. Chang, MD PhD

    Howard Y. Chang, MD PhD

    Virginia and D. K. Ludwig Professor of Cancer Genomics and of Genetics

    Current Research and Scholarly InterestsOur research is focused on how the activities of hundreds or even thousands of genes (gene parties) are coordinated to achieve biological meaning. We have pioneered methods to predict, dissect, and control large-scale gene regulatory programs; these methods have provided insights into human development, cancer, and aging.

  • Jennifer Chen, MD

    Jennifer Chen, MD

    Clinical Associate Professor, Dermatology

    BioJennifer K. Chen, M.D., is a Clinical Assistant Professor of Dermatology. She co-directs the medical student sub-internship program. She completed medical school at Johns Hopkins University, residency at Johns Hopkins and University of California, Irvine, and completed a Howard Hughes Fellowship at Stanford University. Her clinical interests include complex medical dermatology, skin cancer, inpatient dermatology, and contact dermatitis.

  • Richard Owguan Chen

    Richard Owguan Chen

    Clinical Instructor, Dermatology

    BioRichard Chen, M.D., is a Clinical Instructor of Dermatology at Stanford and Chief Scientific Officer at Personalis, Inc. He attended medical school and completed residency at Stanford University, serving as Chief Resident in his final year. His interests include general dermatology, genetics, bioinformatics and technology innovation for improved health care delivery.

  • Albert Chiou, MD

    Albert Chiou, MD

    Clinical Assistant Professor, Dermatology

    BioDr. Albert Chiou joined Stanford Medicine in September 2017 as a Clinical Assistant Professor of Dermatology. Dr. Chiou earned his Bachelor of Science from Stanford University in 2007. He received his medical degree from Harvard Medical School, where he also completed a joint business degree. Dr. Chiou performed his dermatology residency at Stanford University and served as Chief Resident in his final year. His clinical focus is general medical dermatology, including acne, psoriasis, skin cancer, and dermatologic surgery.

    Dr. Chiou is also actively involved in clinical trial research investigating new treatments for a variety of poorly treated, chronic dermatologic conditions.

  • Hani Choudhry, MSc DPhil

    Hani Choudhry, MSc DPhil

    Visiting Assistant Professor, Dermatology

    BioDr. Hani Choudhry is a Visiting Assistant Professor at Howard Chang’s Lab at the NIH Center of Excellence in Genomic Science, Center for Personal Dynamic Regulome, Stanford University. He is a full-time Assistant Professor of Cancer Genomics at King Abdulaziz University (KAU), Saudi Arabia. He also the Director of Cancer and Mutagenesis Research Unit at King Fahd Center for Medical Research.

    Dr. Choudhry has received a number of international and prestigious awards including two American Association for Cancer Research (AACR) Scholar-in-Training Awards at the 2014 San Antonio Breast Cancer Annual Symposium (SABCS) and AACR Annual Meeting 2017, the OECI-Eurocan Platform Translational Cancer Research Fellowship, the Susan G. Komen for the Cure Award and Proffered Paper Award for Non-coding RNA in cancers in the 23rd Biennial European Association for Cancer Research Congress, the ASHG/Charles J. Epstein Trainee Award for Excellence in Human Genetics Research (SF), the National Cancer Research Institute (NCRI) Prize Award. Recently, Dr. Choudhry has received the prestigious Professional Achievement Award 2016 - UK Alumni Awards from the British Ambassador to Saudi Arabia and the UAE International Genetic Disorders Prevention Award 2016-2017 - Scientific Excellence Award in GCC from the UAE Genetic Disease Association, UAE.

    His current scientific interests focus on non-coding transcriptome and epigenomic profiling of cancer cells, and the integration of both clinical and pathological information with data generated from high-throughput molecular techniques. His work addresses the impact of intra-tumor gene expression heterogeneity on the biology and clinical behavior of tumors.In addition, development of high-throughput CRISPR and novel functional genomic technologies.

  • Derek Chu, MD

    Derek Chu, MD

    Clinical Assistant Professor, Dermatology
    Clinical Assistant Professor, Pediatrics - Operations

    BioDr. Derek H. Chu joined our faculty in October 2016 as a Clinical Assistant Professor of Dermatology. He received his Bachelor of Science in Biology from Massachusetts Institute of Technology in 2007, and earned his medical degree from the University of Pennsylvania in 2011. He completed his Pediatrics Internship at the Children’s Hospital of Philadelphia in 2012, Dermatology Residency at the University of Pennsylvania in 2015, serving as Chief Resident in his final year, and Pediatric Dermatology Fellowship at UCSF in June 2016.

    Dr. Chu's clinical and professional interests encompass a wide array of topics within pediatric dermatology, including vascular tumors and malformations, inflammatory skin diseases, dermato-oncology, neonatal dermatology, and procedural dermatology.

  • Lorinda Chung MD MS

    Lorinda Chung MD MS

    Associate Professor of Medicine (Immunology and Rheumatology) and, by courtesy, of Dermatology at the Palo Alto Veterans Affairs Health Care Center

    Current Research and Scholarly InterestsMy research interests focus on all aspects of systemic sclerosis. I am currently involved in clinical, translational, and epidemiologic research in these areas, and dedicate a substantial portion of my research time to investigator-initiated and multi-center clinical trials of novel therapeutics for the treatment of systemic sclerosis.